Madhusoodanan Subramoniam, Bogunovic Olivera J, Moise Despina, Brenner Ronald, Markowitz Sheldon, Sotelo Jorge
St. John's Episcopal Hospital, South Shore,327 Beach 19th street, Far Rockaway, New York, USA.
Adverse Drug React Toxicol Rev. 2002;21(1-2):17-29. doi: 10.1007/BF03256181.
Psychotropic medication-induced hyponatraemia is an uncommon but important clinical problem with potential serious consequences if not recognised and treated early. Several risk factors have been associated with the development of hyponatraemia. This article reviews reported cases of hyponatraemia associated with the use of psychotropic medications and evaluates possible risk factors and causes. The data were sourced by a search of Medline for reports of hyponatraemia associated with the use of psychotropic medication between January 1966 and December 2000 and a search of US Food and Drug Administration (FDA) spontaneous reporting system database between January 1966 and December 1999. All the reports were included in this review. In the case reports the following data were assessed: age, gender, daily dosage, days to onset, days to recovery, medical condition, concurrent medications. Several risk factors were identified: advanced age, female gender, use of other medications, medical comorbidity. The risk of hyponatraemia was found to be higher during the first 2 weeks of treatment. Administration of the dosage of the drug was not found to be related to the development of hyponatraemia. Hyponatraemia can cause confusion, agitation and lethargy. Any change in the course of illness should alert the physician to the possibility of hyponatraemia.
精神药物引起的低钠血症是一个不常见但重要的临床问题,如果不及早识别和治疗可能会导致严重后果。低钠血症的发生与多种风险因素有关。本文回顾了与使用精神药物相关的低钠血症报告病例,并评估了可能的风险因素和病因。数据来源于对1966年1月至2000年12月期间Medline中与使用精神药物相关的低钠血症报告的检索,以及对1966年1月至1999年12月期间美国食品药品监督管理局(FDA)自发报告系统数据库的检索。所有报告均纳入本综述。在病例报告中,评估了以下数据:年龄、性别、每日剂量、发病天数、恢复天数、医疗状况、同时使用的药物。确定了几个风险因素:高龄、女性、使用其他药物、合并症。发现治疗的前2周内低钠血症的风险较高。未发现药物剂量与低钠血症的发生有关。低钠血症可导致意识模糊、躁动和嗜睡。病程中的任何变化都应提醒医生注意低钠血症的可能性。